Aidan O’Brien, Ph.D., M.Pharm., M.Sc.

Aidan O’Brien, Ph.D., joined the Laboratory of Translational Genomics (LTG) in 2019 as a predoctoral fellow through the NIH Graduate Partnership Program. He earned his Ph.D. in cancer genetics in 2024, focusing on the functional characterization of non-coding genetic variants implicated in pancreatic cancer under the mentorship of Laufey Amundadottir, Ph.D., senior investigator. He previously received an M.Sc. in cancer medicine in 2019 and an M.Pharm. in pharmacy in 2017 from Queen’s University Belfast.

In LTG, Dr. O’Brien focuses his postdoctoral research on identifying and characterizing genetic risk factors for melanoma under the mentorship of Kevin Brown, Ph.D., senior investigator.